- Gastric, oesophageal, pancreatic, biliary, liver and colorectal cancers
- Genetics of cancer
- Genetic testing for inherited cancers and cancer risk testng
Dr Krell’s DPhil research was undertaken at Oxford University, at the Wellcome Trust Centre for Human Genetics, and was funded by Cancer Research UK and HCA. Dr Krell’s research investigated the role that genetic mutations in genes controlling cellular metabolism play in the development of cancer, with the aim of identifying new therapeutic targets in this area. He continues to be involved in clinical research and clinical trials aimed at identifying new cancer therapies, with a focus on gastrointestinal and hepatobiliary cancers. He maintains an interest in cancer genetics and is involved in genetic testing for familial cancers with a particular focus on colorectal, gastro-oesophageal and pancreatic cancer.
Dr Krell has published several peer-reviewed papers in journals such as the British Journal of Cancer and Lancet Oncology. His clinical work focuses on the management of patients with gastric, oesophageal, colorectal, pancreatic, liver and biliary tract cancers using chemotherapy, targeted therapy and immunotherapies. He also manages patients with cancer of unknown primary and is the clinical lead at his institution for this. He also acts as the clinical lead for gastro-oesophageal and hepatobiliary cancer.
Consultant Medical OncologistRoyal Free London NHS Foundation Trust
Leeds University Medical School2003
University of Oxford2014
Treatment enquiries: +44 (0) 207 616 7693Consultant appointments: +44 (0) 207 616 7693 Prices for self funding patients: +44 (0) 203 219 3315Physiotherapy appointments: +44 (0) 207 616 7651 X-ray and scan appointments: +44 (0) 207 616 7653Invoice and payment enquiries: +44 (0) 207 616 7708